Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Regeneron Pharmaceuticals' Q1 2024 Earnings: What to Expect

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988 and focuses on inventing life-transforming medicines for people...

REGN : 911.01 (+0.49%)
$SPX : 5,071.63 (+0.02%)
XBI : 81.88 (-2.45%)
3 Top ETFs I Plan to Buy in April

These ETFs are easy, low-cost ways to invest in certain themes.

JPM : 193.67 (+0.31%)
STT : 74.15 (-0.19%)
XBI : 81.88 (-2.45%)
SPHY : 22.96 (-0.56%)
JEPI : 55.97 (-0.80%)
Wall Street Thinks These 2 Biotech Stocks Could Soar in 2024

These two biotech stocks sport notable 12-month price targets. However, they are also uber-risky.

BIIB : 201.96 (-0.01%)
XBI : 81.88 (-2.45%)
XLK : 194.85 (-1.61%)
OCUL : 4.50 (-3.02%)
LRMR : 6.46 (unch)
3 Thematic Growth ETFs to Load Up on Right Now

These three thematic ETFs could be potent growth vehicles in years to come.

XBI : 81.88 (-2.45%)
IHI : 55.45 (-0.34%)
SMH : 206.42 (-0.78%)
20 November 2023 Covered Calls Trades Yielding 13.3% to15.9% Update #2

Small and large dividend stock and ETF investors can use covered calls and puts trades to generate monthly income from options premiums and options trading.

XBI : 81.88 (-2.45%)
AMZN : 167.78 (-4.99%)
DHR : 249.38 (-0.41%)
PAYC : 185.76 (-1.14%)
DHI : 142.29 (-2.62%)
CPB : 45.91 (+0.81%)
10 November 2023 Covered Calls Trades Update #1

Small and large dividend stock and ETF investors can use covered calls and puts trades to generate monthly income from options premiums and options trading. DONALD E. L. JOHNSON

BG : 106.58 (+0.75%)
DUK : 99.07 (+0.11%)
DHI : 142.29 (-2.62%)
GIS : 72.30 (+0.96%)
KO : 62.48 (+1.51%)
MRK : 131.14 (+3.26%)
PAYC : 185.76 (-1.14%)
XBI : 81.88 (-2.45%)
ZBH : 121.17 (-0.29%)
AMZN : 167.78 (-4.99%)
CPB : 45.91 (+0.81%)
WBA : 17.88 (+0.39%)
It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy

The market's dour reaction to Roivant Sciences' latest deal doesn't add up.

RHHBY : 30.5400 (-2.24%)
XBI : 81.88 (-2.45%)
ROIV : 10.64 (-2.39%)
PFE : 26.38 (+0.42%)
7 November 2023 Covered Calls Trades Are Yielding 13.3%

Small and large dividend stock and ETF investors can use covered calls and puts trades to generate monthly income from options premiums and options trading.

MRK : 131.14 (+3.26%)
DHI : 142.29 (-2.62%)
GIS : 72.30 (+0.96%)
PAYC : 185.76 (-1.14%)
XBI : 81.88 (-2.45%)
ZBH : 121.17 (-0.29%)
September Puts Options Trades Update #5

Small and large dividend stock and ETF investors can use covered calls and puts trades to generate monthly income from options premiums and options trading.

ACN : 307.65 (-1.88%)
GD : 282.85 (+0.62%)
GNRC : 136.56 (-0.45%)
DG : 142.92 (-0.17%)
MRK : 131.14 (+3.26%)
V : 273.14 (-0.68%)
XBI : 81.88 (-2.45%)
XLY : 171.32 (-1.65%)
DHR : 249.38 (-0.41%)
DVN : 52.22 (+0.23%)
KHC : 38.93 (+0.93%)
MRNA : 107.19 (-1.53%)
September Puts Options Trades Update #4

Small and large dividend stock and ETF investors can use covered calls and puts trades to generate monthly income from options premiums and options trading

V : 273.14 (-0.68%)
XBI : 81.88 (-2.45%)
XLY : 171.32 (-1.65%)
DG : 142.92 (-0.17%)

Barchart Exclusives

1 Overlooked Small-Cap Stock With 58% Upside Potential
This small-cap stock just beat and raised on earnings, and it's trading at a steep discount to historical multiples. Here's a closer look at this tech sector standout. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar